Name
| Firma | Arbeiten | |
| Priv.Doz. Dr. Michael Potente | Max-Planck-Institut für Herz- und Lungenforschung | FOXO1 couples metabolic activity and growth state in the vascular endothelium | |
Prof. Dr. Matthias Gunzer | Universität Duisburg-Essen | Institut für Experimentelle Immunologie und Bildgebung | ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo |
Prof. Dr. Michael Soyka | Privatklinik Meiringen, Schweiz | 1) New developments in the management of opiod dependence: focus on sublingual buprenorphine-naloxone 2) Buprenorphine-Naloxane Treatment in Opioid Dependance and Risk of Liver Enzyme Elevation: Results from a 12-Month Observational Study | |
| Prof. Klaus Brandenburg | Forschungszentrum Borstel | Leibniz-Zentrum für Medizin und Biowissenschaften | 1) Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can beneutralized by synthetic anti-endotoxin peptides 2) Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflamation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum |
Prof. Tobias Schürholz | Universitätsklinikum der RWTH Aachen | Klinik für Operative Intensivmedizin und Intermediate Care | 1) Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can beneutralized by synthetic anti-endotoxin peptides 2) Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflamation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum |
Dr. Janika Viereck und Prof. Dr. Thomas Thum | Medizinische Hochschule Hannover | Molekulare und Translationale Therapiestrategien | Long noncoding RNA Chast promotes cardiac remodeling |